메뉴 건너뛰기




Volumn 74, Issue 1, 2013, Pages 51-56

Quantitative electroencephalogram Biomarkers for predicting likelihood and speed of achieving sustained remission in Major Depression: A report from the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD) trial

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BIOLOGICAL MARKER; ESCITALOPRAM;

EID: 84873880515     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10m06813     Document Type: Article
Times cited : (25)

References (32)
  • 1
    • 33749057523 scopus 로고    scopus 로고
    • Prevalence and effects of mood disorders on work performance in a nationally representative sample of US workers
    • Kessler RC, Akiskal HS, Ames M, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of US workers. Am J Psychiatry. 2006;163(9):1561-1568.
    • (2006) Am J Psychiatry , vol.163 , Issue.9 , pp. 1561-1568
    • Kessler, R.C.1    Akiskal, H.S.2    Ames, M.3
  • 2
    • 1242338645 scopus 로고    scopus 로고
    • The economic burden of depression in the United States: How did it change between 1990 and 2000?
    • Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64(12):1465-1475.
    • (2003) J Clin Psychiatry , vol.64 , Issue.12 , pp. 1465-1475
    • Greenberg, P.E.1    Kessler, R.C.2    Birnbaum, H.G.3
  • 3
    • 33644634660 scopus 로고    scopus 로고
    • An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: A sequenced treatment alternatives to relieve depression trial report
    • Rush AJ, Bernstein IH, Trivedi MH, et al. An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry. 2006;59(6):493-501.
    • (2006) Biol Psychiatry , vol.59 , Issue.6 , pp. 493-501
    • Rush, A.J.1    Bernstein, I.H.2    Trivedi, M.H.3
  • 4
    • 33846885880 scopus 로고    scopus 로고
    • Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: Prevalence and implications
    • Cusin C, Fava M, Amsterdam JD, et al. Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications. J Clin Psychiatry. 2007;68(1):52-57.
    • (2007) J Clin Psychiatry , vol.68 , Issue.1 , pp. 52-57
    • Cusin, C.1    Fava, M.2    Amsterdam, J.D.3
  • 5
    • 33846227445 scopus 로고    scopus 로고
    • Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder
    • Papakostas GI, Petersen T, Sklarsky KG, et al. Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. Psychiatry Res. 2007;149(1-3):195-200.
    • (2007) Psychiatry Res , vol.149 , Issue.1-3 , pp. 195-200
    • Papakostas, G.I.1    Petersen, T.2    Sklarsky, K.G.3
  • 6
    • 35348826316 scopus 로고    scopus 로고
    • A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder
    • Perahia DG, Pritchett YL, Kajdasz DK, et al. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. J Psychiatr Res. 2008;42(1):22-34.
    • (2008) J Psychiatr Res , vol.42 , Issue.1 , pp. 22-34
    • Perahia, D.G.1    Pritchett, Y.L.2    Kajdasz, D.K.3
  • 7
    • 73749084835 scopus 로고    scopus 로고
    • Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder
    • Hunter AM, Muthen BO, Cook IA, et al. Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. J Psychiatr Res. 2010;44(2):90-98.
    • (2010) J Psychiatr Res , vol.44 , Issue.2 , pp. 90-98
    • Hunter, A.M.1    Muthen, B.O.2    Cook, I.A.3
  • 8
    • 1942473113 scopus 로고    scopus 로고
    • Evidence-based strategies for achieving and sustaining full remission in depression: Focus on metaanalyses
    • Lam RW, Kennedy SH. Evidence-based strategies for achieving and sustaining full remission in depression: focus on metaanalyses. Can J Psychiatry. 2004;49(suppl 1):17S-26S.
    • (2004) Can J Psychiatry , vol.49 , Issue.SUPPL. 1
    • Lam, R.W.1    Kennedy, S.H.2
  • 9
    • 2542427725 scopus 로고    scopus 로고
    • Pharmacologic considerations in treating depression: A patient-centered approach
    • Ticknor CB. Pharmacologic considerations in treating depression: a patient-centered approach. J Manag Care Pharm. 2004;10(suppl):S8-S15.
    • (2004) J Manag Care Pharm , vol.10 , Issue.SUPPL.
    • Ticknor, C.B.1
  • 10
    • 31544452090 scopus 로고    scopus 로고
    • A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder
    • Papakostas GI, Perlis RH, Scalia MJ, et al. A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder. J Clin Psychopharmacol. 2006;26(1):56-60.
    • (2006) J Clin Psychopharmacol , vol.26 , Issue.1 , pp. 56-60
    • Papakostas, G.I.1    Perlis, R.H.2    Scalia, M.J.3
  • 11
    • 69649101602 scopus 로고    scopus 로고
    • Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in major depressive disorder: Results of the BRITE-MD study
    • Leuchter AF, Cook IA, Marangell LB, et al. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in major depressive disorder: results of the BRITE-MD study. Psychiatry Res. 2009;169(2):124-131.
    • (2009) Psychiatry Res , vol.169 , Issue.2 , pp. 124-131
    • Leuchter, A.F.1    Cook, I.A.2    Marangell, L.B.3
  • 12
    • 69649095385 scopus 로고    scopus 로고
    • Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder
    • Leuchter AF, Cook IA, Gilmer WS, et al. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res. 2009;169(2):132-138.
    • (2009) Psychiatry Res , vol.169 , Issue.2 , pp. 132-138
    • Leuchter, A.F.1    Cook, I.A.2    Gilmer, W.S.3
  • 13
    • 0036285108 scopus 로고    scopus 로고
    • Early changes in prefrontal activity characterize clinical responders to antidepressants
    • Cook IA, Leuchter AF, Morgan M, et al. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology. 2002;27(1):120-131.
    • (2002) Neuropsychopharmacology , vol.27 , Issue.1 , pp. 120-131
    • Cook, I.A.1    Leuchter, A.F.2    Morgan, M.3
  • 14
    • 69649088116 scopus 로고    scopus 로고
    • Frontal EEG at week 1 predicts clinical response to SSRI treatment in MDD
    • May 20-25 Toronto, Ontario, Canada
    • Iosifescu DV, Greenwald SD, Smith CP, et al. Frontal EEG at week 1 predicts clinical response to SSRI treatment in MDD. Poster no. 231 presented at the annual meeting of the American Psychiatric Association; May 20-25, 2006; Toronto, Ontario, Canada. 15.
    • (2006) Annual Meeting of the American Psychiatric Association , vol.15
    • Iosifescu, D.V.1    Greenwald, S.D.2    Smith, C.P.3
  • 15
    • 69649099949 scopus 로고    scopus 로고
    • Frontal EEG at 1 week predicts response to treatment with citalopram in MDD
    • May 20-25 Toronto, Ontario, Canada
    • Poland R, Greenwald SD, Smith CP, et al. Frontal EEG at 1 week predicts response to treatment with citalopram in MDD. Poster no. 269 presented at the annual meeting of the American Psychiatric Association; May 20-25, 2006; Toronto, Ontario, Canada.
    • (2006) The Annual Meeting of the American Psychiatric Association
    • Poland, R.1    Greenwald, S.D.2    Smith, C.P.3
  • 16
    • 70349487527 scopus 로고    scopus 로고
    • Frontal EEG predictors of treatment outcome in major depressive disorder
    • Iosifescu DV, Greenwald S, Devlin P, et al. Frontal EEG predictors of treatment outcome in major depressive disorder. Eur Neuropsychopharmacol. 2009;19(11):772-777.
    • (2009) Eur Neuropsychopharmacol. , vol.19 , Issue.11 , pp. 772-777
    • Iosifescu, D.V.1    Greenwald, S.2    Devlin, P.3
  • 17
    • 30044433660 scopus 로고    scopus 로고
    • Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
    • STAR D Study Team
    • Trivedi MH, Rush AJ, Wisniewski SR, et al; STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40.
    • (2006) Am J Psychiatry , vol.163 , Issue.1 , pp. 28-40
    • Trivedi, M.H.1    Rush, A.J.2    Wisniewski, S.R.3
  • 18
    • 0032421570 scopus 로고    scopus 로고
    • The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
    • quiz 34-57
    • Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33, quiz 34-57.
    • (1998) J Clin Psychiatry , vol.59 , Issue.SUPPL. 20 , pp. 22-33
    • Sheehan, D.V.1    Lecrubier, Y.2    Sheehan, K.H.3
  • 19
    • 45349107889 scopus 로고    scopus 로고
    • Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 british association for psychopharmacology guidelines
    • Anderson IM, Ferrier IN, Baldwin RC, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2008;22(4):343-396.
    • (2008) J Psychopharmacol , vol.22 , Issue.4 , pp. 343-396
    • Anderson, I.M.1    Ferrier, I.N.2    Baldwin, R.C.3
  • 20
    • 69649095792 scopus 로고    scopus 로고
    • Canadian network for mood and anxiety treatments (canmat) clinical guidelines for the management of major depressive disorder in adults 3: Pharmacotherapy
    • Canadian Network for Mood and Anxiety Treatments (CANMAT)
    • Lam RW, Kennedy SH, Grigoriadis S, et al Canadian Network for Mood and Anxiety Treatments (CANMAT). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults, 3: pharmacotherapy. J Affect Disord. 2009;117(suppl 1):S26-S43.
    • (2009) J Affect Disord , vol.117 , Issue.SUPPL. 1
    • Lam, R.W.1    Kennedy, S.H.2    Grigoriadis, S.3
  • 21
    • 33847221833 scopus 로고    scopus 로고
    • The concept of recovery in major depression
    • Fava GA, Ruini C, Belaise C. The concept of recovery in major depression. Psychol Med. 2007;37(3):307-317.
    • (2007) Psychol Med , vol.37 , Issue.3 , pp. 307-317
    • Fava, G.A.1    Ruini, C.2    Belaise, C.3
  • 22
    • 79952582418 scopus 로고    scopus 로고
    • Growth modeling with nonignorable dropout: Alternative analyses of the STAR D antidepressant trial
    • Muthen B, Asparouhov T, Hunter AM, et al. Growth modeling with nonignorable dropout: alternative analyses of the STAR D antidepressant trial. Psychol Methods. 2011;16(1):17-33.
    • (2011) Psychol Methods , vol.16 , Issue.1 , pp. 17-33
    • Muthen, B.1    Asparouhov, T.2    Hunter, A.M.3
  • 23
    • 41549162499 scopus 로고    scopus 로고
    • Long-term outcome of major depressive disorder in psychiatric patients is variable
    • Holma KM, Holma IA, Melartin TK, et al. Long-term outcome of major depressive disorder in psychiatric patients is variable. J Clin Psychiatry. 2008;69(2):196-205.
    • (2008) J Clin Psychiatry , vol.69 , Issue.2 , pp. 196-205
    • Holma, K.M.1    Holma, I.A.2    Melartin, T.K.3
  • 24
    • 70349127301 scopus 로고    scopus 로고
    • Early symptom change prediction of remission in depression treatment
    • Katz MM, Meyers AL, Prakash A, et al. Early symptom change prediction of remission in depression treatment. Psychopharmacol Bull. 2009;42(1): 94-107.
    • (2009) Psychopharmacol Bull , vol.42 , Issue.1 , pp. 94-107
    • Katz, M.M.1    Meyers, A.L.2    Prakash, A.3
  • 25
    • 35348859576 scopus 로고    scopus 로고
    • Medication use patterns and two-year outcome in first-admission patients with major depressive disorder with psychotic features
    • Craig TJ, Grossman S, Bromet EJ, et al. Medication use patterns and two-year outcome in first-admission patients with major depressive disorder with psychotic features. Compr Psychiatry. 2007;48(6):497-503.
    • (2007) Compr Psychiatry , vol.48 , Issue.6 , pp. 497-503
    • Craig, T.J.1    Grossman, S.2    Bromet, E.J.3
  • 26
    • 0025865067 scopus 로고
    • Long-term treatment of depression
    • suppl
    • Kupfer DJ. Long-term treatment of depression. J Clin Psychiatry. 1991;52(suppl):28-34.
    • (1991) J Clin Psychiatry , vol.52 , pp. 28-34
    • Kupfer, D.J.1
  • 27
    • 33646054531 scopus 로고    scopus 로고
    • Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population: The role of clinical, psychosocial and genetic variables
    • Dotoli D, Spagnolo C, Bongiorno F, et al. Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population: the role of clinical, psychosocial and genetic variables. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(3):442-448.
    • (2006) Prog Neuropsychopharmacol Biol Psychiatry , vol.30 , Issue.3 , pp. 442-448
    • Dotoli, D.1    Spagnolo, C.2    Bongiorno, F.3
  • 28
    • 77954871164 scopus 로고    scopus 로고
    • Does night-time cortisol excretion normalize in the long-term course of depression?
    • Scharnholz B, Lederbogen F, Feuerhack A, et al. Does night-time cortisol excretion normalize in the long-term course of depression? Pharmacopsychiatry. 2010;43(5):161-165.
    • (2010) Pharmacopsychiatry , vol.43 , Issue.5 , pp. 161-165
    • Scharnholz, B.1    Lederbogen, F.2    Feuerhack, A.3
  • 29
    • 0242509965 scopus 로고    scopus 로고
    • White matter hyperintensity progression and late-life depression outcomes
    • Taylor WD, Steffens DC, MacFall JR, et al. White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry. 2003;60(11):1090-1096.
    • (2003) Arch Gen Psychiatry , vol.60 , Issue.11 , pp. 1090-1096
    • Taylor, W.D.1    Steffens, D.C.2    MacFall, J.R.3
  • 30
    • 0020696493 scopus 로고
    • The dexamethasone suppression test and ECT outcome: A six-month follow-up
    • Coryell W, Zimmerman M. The dexamethasone suppression test and ECT outcome: a six-month follow-up. Biol Psychiatry. 1983;18(1):21-27.
    • (1983) Biol Psychiatry , vol.18 , Issue.1 , pp. 21-27
    • Coryell, W.1    Zimmerman, M.2
  • 31
    • 84861829390 scopus 로고    scopus 로고
    • Brain-volume increase with sustained remission in patients with treatment-resistant unipolar depression
    • Phillips JL, Batten LA, Aldosary F, et al. Brain-volume increase with sustained remission in patients with treatment-resistant unipolar depression. J Clin Psychiatry. 2012;73(5):625-631.
    • (2012) J Clin Psychiatry , vol.73 , Issue.5 , pp. 625-631
    • Phillips, J.L.1    Batten, L.A.2    Aldosary, F.3
  • 32
    • 75749098889 scopus 로고    scopus 로고
    • A new paradigm for the prediction of antidepressant treatment response
    • Leuchter AF, Cook IA, Hunter AM, et al. A new paradigm for the prediction of antidepressant treatment response. Dialogues Clin Neurosci. 2009;11(4):435-446.
    • (2009) Dialogues Clin Neurosci , vol.11 , Issue.4 , pp. 435-446
    • Leuchter, A.F.1    Cook, I.A.2    Hunter, A.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.